Lv2
106 积分 2025-02-28 加入
[A New Molecular Targeted Agent for Gastric Cancer-The Anti-Claudin 18.2 Antibody, Zolbetuximab]
1个月前
已关闭
ILUSTRO: Phase II Multicohort Trial of Zolbetuximab in Patients with Advanced or Metastatic Claudin 18.2–Positive Gastric or Gastroesophageal Junction Adenocarcinoma
1个月前
已完结
Inverse expression of S100A4 and E-cadherin is associated with metastatic potential in gastric cancer
1个月前
已关闭
[Progress of individualized precision therapy for peritoneal metastasis in gastric cancer]
1个月前
已完结
Comprehensive proteomic analysis and multidimensional model construction of peritoneal metastasis in gastric cancer
3个月前
已完结
Overcoming radiation-induced PD-L1 upregulation by novel gadolinium-palladium nanoplatforms for enhanced tumor radio-immunotherapy
4个月前
已完结
Dimeric PD-L1 specific affibody grafted Fe-based nanosheets for tumor-targeting dual-mode magnet resonance imaging and enhancement of Photothermal-Immunotherapy
4个月前
已完结
Coronary Artery Fistulas
6个月前
已完结
Coronary Artery Fistulas
6个月前
已完结
皖公网安备34019202002308
